Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Start Codon Ltd.. (12/11/19). "Press Release: Start Codon and One Nucleus Partner to Support UK Life Science Ecosystem. Start Codon Cohort Companies to Receive One Nucleus Membership Benefits". Cambridge.

Region Region United Kingdom (GB)
Organisations Organisation Start Codon Ltd.
  Organisation 2 One Nucleus
Products Product business services
Index term Index term Start Codon–One Nucleus: business services, 201912– service support of start-ups participating in Start Codon accelerator programme by One Nucleus
Persons Person Mellad, Jason (Start Codon 201904– CEO before Cambridge Epigenetix CEO)
  Person 2 Jones, Tony (One Nucleus 201708– CEO before Director of Business Development)

Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with One Nucleus, a membership organisation for life science and healthcare companies. Under the terms of the partnership agreement, One Nucleus will support and profile the life science and healthcare start-ups participating in the Start Codon accelerator programme.

Founded in April 2019, Start Codon aims to identify and recruit high potential life science and healthcare companies from across the UK and beyond, provide seed-funding, and leverage the worldclass resources of the Cambridge Cluster to reduce risk and prepare them for a successful Series A fundraise. Commencing 6th January 2020, One Nucleus will provide Start Codon cohort companies with gold membership benefits, over 12 months, focussed on raising their profile and helping to access new industry contacts. Gold membership benefits include an online company profile on One Nucleus’ ‘Member Directory’, discounted training in events such as Genesis and ON Helix, preferred supplier agreement discounts and participation in special interest groups. Given One Nucleus’ extensive network of life science start-ups, the partnership will also help Start Codon secure disruptive platform technology companies for its programme.

Start Codon CEO, Dr Jason Mellad, will be participating in the “Meeting Biotech Rising Stars” panel session at the One Nucleus Genesis conference taking place on December 11th at the QEII Centre, Westminster, London. More information can be found here.

Dr Jason Mellad, CEO at Start Codon, said: “Like Start Codon, One Nucleus is committed to playing an active and supportive role in enabling the success of the UK life science cluster, particularly that in the East of England and London. Having One Nucleus membership benefits will be extremely valuable to our cohort, particularly for developing a network of industry leading contacts.”

Tony Jones, CEO at One Nucleus, said: “One Nucleus can provide local, UK-wide and international connectivity to enable companies to maximise their performance within the life sciences and healthcare industry. Therefore, we are excited to partner with Start Codon to help facilitate the next generation of innovative and entrepreneurial companies.”


Photo: For high-resolution images please contact Zyme Communications.
Jason Mellad CEO Start Codon
Tony Jones CEO One Nucleus

For further information, please contact:
Lorna Cuddon
Zyme Communications
Tel: +44(0)7811996942

To opt-out from receiving press releases from Zyme Communications please email To view our privacy policy, please click here.

Notes to Editors

About Start Codon

Start Codon is a new model of life science and healthcare business accelerator, and the first in Cambridge, UK to provide companies with a combination of seed funding, facilities, mentoring and access to a dedicated team and network of industry leading contacts. Investors in Start Codon include Cambridge Innovation Capital, the Babraham Research Campus through Babraham Bioscience Technologies, Genentech, a member of the Roche Group, Dr Jonathan Milner and Dr Ian Tomlinson.

Founded to identify ideas that have the potential to impact the diagnosis, prevention and/or treatment of disease, and support their path to successful Series A funding, Start Codon aims to revolutionise the way life science and healthcare innovation is commercialised by reducing risk in investment opportunities and developing companies in the Cambridge, UK cluster that are built to succeed globally.

Follow Start Codon on Twitter @StartCodon and LinkedIn @Start Codon

About One Nucleus

Established in 1997, One Nucleus is an award winning not-for-profit Life Sciences & Healthcare membership organisation centred on the Greater London-Cambridge-East of England corridor. Headquartered in Cambridge, at the heart of Europe’s largest Life Sciences & Healthcare cluster, we support those institutions, companies and individuals undertaking activity in or with the above region.

Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance. This support helping them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multidisciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what we continually strive to deliver.

Follow One Nucleus on Twitter @OneNucleus and LinkedIn @One Nucleus

Record changed: 2019-12-19


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Start Codon Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top